Reduced coenzyme Q10 crystal having excellent stability

US9556098B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9556098-B2
Application numberUS-201615181511-A
CountryUS
Kind codeB2
Filing dateJun 14, 2016
Priority dateJun 24, 2011
Publication dateJan 31, 2017
Grant dateJan 31, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

With respect to reduced coenzyme Q10, there has been no report about the presence of crystal polymorphism, and it has been considered that a conventionally obtained crystal form is only one form. The present invention relates to a reduced coenzyme Q10 crystal having an endothermic peak indicating melting at 54±2° C. during temperature rise at a rate of 5° C./min by differential scanning calorimetry (DSC), and/or to a reduced coenzyme Q10 crystal showing characteristic peaks at diffraction angles (2θ±0.2°) of 11.5°, 18.2°, 19.3°, 22.3°, 23.0° and 33.3° by powder X-ray (Cu—Kα) diffraction. The crystal form is a novel reduced coenzyme Q10 crystal which has a higher melting point and a lower solubility in a solvent, and is more excellent in stability than the conventionally known reduced coenzyme Q10 crystal.

First claim

Opening claim text (preview).

The invention claimed is: 1. A composition, comprising: a reduced coenzyme Q10 crystal showing characteristic peaks at diffraction angles in 20±0.2° of 11.5°, 18.2°, 19.3°, 22.3°, 23.0° and 33.3° in powder Cu—Kα X-ray diffraction, wherein the composition is in a solid form and the composition is at least one of food, nutritional functional food, specified health food, nutritious supplement, nutrient, animal drug, feed, cosmetic, medicament, treatment drug, prevention drug, and pet food. 2. The composition of claim 1 , further comprising: at least one of an excipient, a disintegrator, a lubricant, a binder, an antioxidant, a colorant, an anticoagulation agent, an absorption promoter, and an active ingredient which is not reduced coenzyme Q10. 3. The composition of claim 2 , wherein the active ingredient is at least one of amino acid, vitamin, mineral, polyphenol, organic acid, saccharide, peptide, and protein. 4. The composition of claim 1 , which is in a form of a hard capsule. 5. The composition of claim 2 , which is in a form of a hard capsule. 6. The composition of claim 3 , which is in a form of a hard capsule. 7. The composition of claim 1 , which is in a form of a tablet. 8. The composition of claim 2 , which is in a form of a tablet. 9. The composition of claim 3 , which is in a form of a tablet. 10. The composition of claim 1 , which is in a form of a coated tablet. 11. The composition of claim 2 , which is in a form of a coated tablet. 12. The composition of claim 3 , which is in a form of a coated tablet.

Assignees

Inventors

Classifications

  • Nutrients, e.g. vitamins, minerals · CPC title

  • A23K20/111Primary

    Aromatic compounds · CPC title

  • using additives (addition of substantially indigestible substances A23L33/21) · CPC title

  • Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title

  • C07C46/10Primary

    Separation; Purification; Stabilisation; Use of additives · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9556098B2 cover?
With respect to reduced coenzyme Q10, there has been no report about the presence of crystal polymorphism, and it has been considered that a conventionally obtained crystal form is only one form. The present invention relates to a reduced coenzyme Q10 crystal having an endothermic peak indicating melting at 54±2° C. during temperature rise at a rate of 5° C./min by differential scanning calorim…
Who is the assignee on this patent?
Kaneka Corp
What technology area does this patent fall under?
Primary CPC classification A23K20/111. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).